Teal Health's At-Home Cervical Cancer Screening Gains FDA Approval, Expands Access
Teal Health has developed an at-home cervical cancer screening test, known as the Teal Wand, which has been approved by the U.S. Food and Drug Administration (FDA). This test allows women aged 25 to 65 across the United States to collect vaginal samples at home, which are then mailed to a lab for analysis. The test has shown a 96% accuracy rate in identifying pre-cancer, comparable to traditional in-office tests. The approval and subsequent rollout of this test mark a significant advancement in women's health, providing a convenient and private option for cervical cancer screening. The initiative aligns with efforts to eliminate cervical cancer, a goal supported by improved diagnostics and vaccination schedules. Teal Health's test has been incorporated into guidelines by the American Cancer Society and the Health and Human Services, reflecting its acceptance and potential impact on increasing screening rates. 
